Internal Medicine News

Internal Medicine News

MDedge Internal Medicine and Internal Medicine News serve as the go-to online resources and independent news source for professionals in internal medicine. Established in 1968, Internal Medicine News has been a top provider of news and insights regarding clinical advancements in internal medicine, alongside health care policies and regulations that impact physicians' practices. Both MDedge Internal Medicine and Internal Medicine News are part of Frontline Medical Communications Inc.

National, Trade/B2B, Consumer
English
Magazine

Outlet metrics

Domain Authority
73
Ranking

Global

#80128

United States

#24476

Health/Health

#584

Traffic sources
Monthly visitors

Articles

  • 4 days ago | mdedge.com | Joyce Frieden

    Fla. Ruling Affects Levothyroxine RxA ruling by a Florida administrative law judge means pharmacists in that state now are free to substitute generic levothyroxine sodium for brand-name formulations of the drug. The January decision that removed Synthroid, Levoxyl, Levothroid, and Unithroid from the negative formulary list came in response to a petition last August by Mylan Inc., which markets a generic form of levothyroxine.

  • 5 days ago | mdedge.com | Joyce Frieden

    Feds Launch Sickle Cell CampaignThe National Institute of Diabetes and Digestive and Kidney Diseases is spearheading a campaign to stress the importance of careful hemoglobin A1c testing in people with diabetes who have sickle cell trait or similar blood disorders.

  • 1 week ago | mdedge.com | Megan Brooks

    An artificial intelligence (AI)–enhanced digital collaborative care model led to rapid, clinically significant, and sustained symptom relief for patients with i

  • 1 week ago | mdedge.com | Megan Brooks

    FROM AACR 2025Lingering fatigue and depression are more common among women than men cancer survivors and often lead to a decrease in recreational physical activities in all patients, new data showed.

  • 1 week ago | mdedge.com | Carolyn Brown

    FROM SCAI 2025Patients who received a single antiplatelet drug therapy — usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared with patients who received dual antiplatelet drug therapy. The findings were similar in men and women and in patients with and without coronary artery disease.

Internal Medicine News journalists

Contact details

Address

123 Example Street

City, Country 12345

Phone

+1 (555) 123-4567

No sites or socials found.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations